Analysts Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Price Target at $36.40
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have been assigned a consensus rating of “Hold” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price […]
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have been assigned a consensus rating of “Hold” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price […]
